|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-1-27
|
|
pubmed:abstractText |
Acute pancreatitis remains a serious cause of ERCP-related morbidity. Topical application of lidocaine reportedly blunts cholecystokinin release from intestinal mucosa and reduces sphincter of Oddi spasm. A randomized trial was conducted to evaluate the effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Secondary outcomes evaluated were ease of cannulation and severity of post-ERCP pancreatitis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0016-5107
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
179-84
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14745389-Administration, Topical,
pubmed-meshheading:14745389-Ampulla of Vater,
pubmed-meshheading:14745389-Cholangiopancreatography, Endoscopic Retrograde,
pubmed-meshheading:14745389-Cholecystokinin,
pubmed-meshheading:14745389-Female,
pubmed-meshheading:14745389-Follow-Up Studies,
pubmed-meshheading:14745389-Humans,
pubmed-meshheading:14745389-Lidocaine,
pubmed-meshheading:14745389-Male,
pubmed-meshheading:14745389-Middle Aged,
pubmed-meshheading:14745389-Pancreatitis,
pubmed-meshheading:14745389-Prospective Studies,
pubmed-meshheading:14745389-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis.
|
|
pubmed:affiliation |
Gastroenterology Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
